샘플 요청 목록

 카트 문의
시장보고서
상품코드
1760994

세계의 종양 영양학 시장

Oncology Nutrition
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 352 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

종양 영양학 세계 시장은 2030년까지 25억 달러에 달할 전망

2024년에 15억 달러로 추정되는 종양 영양학 세계 시장은 2024년부터 2030년까지 CAGR 9.6%로 성장하여 2030년에는 25억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 두경부는 CAGR 8.5%를 기록하며 분석 기간 종료시에는 6억 960만 달러에 달할 것으로 예측됩니다. 위·소화기 부문의 성장률은 분석 기간 동안 CAGR 11.7%로 추정됩니다.

미국 시장은 5억 2,190만 달러로 추정, 중국은 CAGR 11.5%로 성장 예측

미국의 종양 영양학 시장은 2024년에는 5억 2,190만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 2억 5,450만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 11.5%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 8.4%와 7.9%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.3%로 성장할 것으로 예측됩니다.

세계의 종양 영양학 시장 - 주요 동향과 촉진요인 정리

종양 영양학이란 무엇이며, 왜 중요한가?

종양 영양학은 암환자의 특별한 식생활 요구를 충족시키는 데 초점을 맞추어 증상 관리와 치료 결과를 개선하는 데 도움을 줍니다. 암과 그 치료는 환자의 식사 능력과 영양 흡수 능력에 큰 영향을 미치기 때문에 영양은 암 치료에서 매우 중요한 역할을 합니다. 적절한 영양 관리는 체력 유지, 감염 위험 감소, 삶의 질 향상, 회복 속도 향상에 도움이 됩니다. 여기에는 특정 영양 결핍을 해결하고, 메스꺼움이나 체중 감소와 같은 치료 부작용을 관리하며, 치료 중 및 치료 후 신체의 면역 체계와 전반적인 건강을 지원하는 맞춤형 식단 계획이 포함됩니다.

연구는 종양 영양학 실무에 어떤 영향을 미쳤는가?

종양 영양학의 지속적인 연구로 특정 식품과 영양소가 종양의 성장, 환자의 회복력, 치료 효과에 미치는 영향에 대한 이해는 점점 더 깊어지고 있습니다. 치료로 인해 화학요법으로 인한 메스꺼움이나 방사선 치료로 인한 체중 감소와 같은 암 치료의 부작용을 줄일 수 있는 특정 영양 전략이 확인되고 있습니다. 예를 들어, 오메가 3 지방산은 암 환자의 근육량을 유지하는 데 도움이 되는 것으로 밝혀졌으며, 과일과 채소에 함유된 항산화제는 화학요법으로 인한 산화 스트레스를 감소시킬 수 있습니다. 이러한 연구와 개발은 암 치료에 있어 보다 효과적이고 근거에 기반한 영양 지침과 개입의 개발을 뒷받침하고 있습니다.

종양 영양학에서 의료 전문가는 어떤 역할을 하는가?

암 전문의, 영양사, 영양사와 같은 의료 전문가는 암 치료에 영양을 통합하는 데 중요한 역할을 합니다. 이들은 협력하여 환자의 영양 상태를 평가하고, 맞춤형 영양 계획을 수립하고, 치료 진행에 따라 이러한 계획을 조정합니다. 이 전문가들이 제공하는 교육은 환자와 간병인이 암 치료 중 식단 선택과 식습관에 대한 정보에 입각한 결정을 내릴 수 있도록 하는 데 필수적입니다. 그들의 전문 지식은 영양 전략이 치료 목표에 안전하고 효과적으로 부합하도록 하여 환자의 결과와 영양 권장 사항 준수를 최적화합니다.

종양 영양학 시장의 성장을 촉진하는 요인은 무엇인가?

종양 영양학 시장의 성장은 전 세계 암 발병률 증가, 영양과 암 회복의 연관성에 대한 인식 증가, 영양 연구의 발전 등 여러 가지 요인에 기인합니다. 세계 인구의 고령화와 함께 암 환자 수는 계속 증가하고 있으며, 암 환자를 지원하기 위한 전문적인 영양 전략에 대한 수요가 증가하고 있습니다. 또한, 식습관이 치료 효과와 환자의 삶의 질에 미치는 영향에 대한 환자와 의료진의 인식이 높아짐에 따라 전체 암 치료 계획에 영양 관리를 통합하는 것에 대한 중요성이 커지고 있습니다. 영양 평가 도구의 기술적 발전과 영양에 초점을 맞춘 연구에 대한 투자 증가는 시장 성장을 더욱 촉진하고 효과적인 실천 방법에 대한 이해와 실행을 강화하고 있습니다.

부문

암종(두경부, 위·소화기, 췌장, 유방, 간, 기타 암종), 최종사용자(병원, 재택 케어, 기타 최종사용자)

조사 대상 기업 사례(총 31개사)

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.07

Global Oncology Nutrition Market to Reach US$2.5 Billion by 2030

The global market for Oncology Nutrition estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Head & Neck, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$609.6 Million by the end of the analysis period. Growth in the Stomach & Gastrointestinal segment is estimated at 11.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$521.9 Million While China is Forecast to Grow at 11.5% CAGR

The Oncology Nutrition market in the U.S. is estimated at US$521.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.5 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.4% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Oncology Nutrition Market - Key Trends & Drivers Summarized

What Is Oncology Nutrition and Why Is It Critical?

Oncology nutrition focuses on meeting the unique dietary needs of cancer patients to help manage symptoms and improve treatment outcomes. Nutrition plays a pivotal role in oncology because cancer and its treatments can significantly affect the patient's ability to eat and absorb nutrients. Proper nutritional care can help maintain body strength, decrease infection risks, improve quality of life, and enhance recovery rates. It involves personalized diet plans that address specific nutritional deficiencies, manage treatment side effects like nausea and weight loss, and support the body’s immune system and overall health during and after treatment.

How Does Research Influence Oncology Nutrition Practices?

Continuous research in oncology nutrition has deepened understanding of how certain foods and nutrients affect tumor growth, patient resilience, and treatment response. Studies have identified specific nutritional strategies that can mitigate the side effects of cancer treatments, such as chemotherapy-induced nausea or radiation-induced weight loss. For instance, omega-3 fatty acids are found to help preserve muscle mass in cancer patients, while antioxidants in fruits and vegetables may reduce the oxidative stress caused by chemotherapy. This growing body of research supports the development of more effective, evidence-based nutritional guidelines and interventions for cancer care.

What Role Do Healthcare Professionals Play in Oncology Nutrition?

Healthcare professionals, including oncologists, dietitians, and nutrition specialists, play a crucial role in integrating nutrition into cancer care. They work collaboratively to assess the nutritional status of patients, devise customized nutrition plans, and adjust these plans as treatment progresses. Education provided by these professionals is vital, as it empowers patients and caregivers to make informed decisions about food choices and dietary habits during cancer treatment. Their expertise ensures that nutritional strategies are safely and effectively aligned with therapeutic goals, thereby optimizing patient outcomes and adherence to nutrition recommendations.

What Drives the Growth in the Oncology Nutrition Market?

The growth in the oncology nutrition market is driven by several factors, including rising global cancer incidence rates, growing awareness of the link between nutrition and cancer recovery, and advancements in nutritional research. As the global population ages, the number of cancer cases continues to climb, increasing the demand for specialized nutritional strategies to support oncology patients. Moreover, as patients and healthcare providers become more aware of how diet impacts treatment efficacy and patient quality of life, there is a greater emphasis on integrating tailored nutritional care into overall cancer treatment plans. Technological advancements in nutritional assessment tools and increased investment in nutrition-focused research further fuel market growth, enhancing the understanding and implementation of effective oncology nutrition practices.

SCOPE OF STUDY:

The report analyzes the Oncology Nutrition market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Cancer Type (Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver, Other Cancer Types); End-Use (Hospitals, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 31 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Tariff Impact on Global Supply Chain Patterns
    • Oncology Nutrition - Global Key Competitors Percentage Market Share in 2025 (E)
    • Global Economic Update
    • Cancer - Food choices, Dietary habits and Cancer risk
    • Significance of Proper Nutrition for Cancer Patients
    • What to Eat in Cancer
    • Importance of Adequate Nutrition during Cancer Treatment
    • Nutrition During Cancer Treatment
    • Common Causes of Nutrition and Malnutrition in Cancer Patients
    • Cancer Treatment Side Effects that are Likely to Cause Dehydration and Malnutrition
    • Commercial Feeding Formulas
    • Factors to be Considered When Selecting a Particular Formula
    • Global Market Analysis and Prospects
    • Global Oncology Nutrition Market Witnesses Rapid Growth
    • Developed Regions Account for Major Share, Developing Regions Witness Rapid Growth
    • Competition
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Cancer Drives the Oncology Nutrition Market
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rising Number of Malnourished Cancer Patients Drive the Demand for Oncology Nutrition Market
    • Patient Diagnosis with Malnutrition
    • Post Treatment Duration and Nutrition for Advanced Cancer
    • Meeting Nutritional Needs of Cancer Patients
    • Nutrition for Breast Cancer Survivorship
    • Introduction of Nutrient-Rich Oncology Nutritional Supplements Ensure Quick Recovery for Cancer Patients
    • Ongoing Research and Development Initiatives Fuel Demand for Oncology Nutrition Products
    • Demand for Gluten and Lactose-Free Enteral Nutrition Formulas Exhibits an Upward Momentum
    • Launch of New Nutritional Products for Cancer Patients
    • Diet for Colon Cancer Surgery
    • Ageing Demographics to Drive Market Demand
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Uptrend in Healthcare Spending Drives Market Demand
    • Enteral Nutrition Market to Remain Buoyant and Strong
    • Oncology Applications Leads EN Market
    • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
    • Changing Health and Social Care Factors Favor Home Enteral Feeding
    • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
    • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Stomach & Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Oncology Nutrition Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제